163 related articles for article (PubMed ID: 20396797)
1. Clinical and biochemical aspects of the carcinoid syndrome in neuroendocrine tumors of the abdominal and retroperitoneal organs and its impact for the disease prognosis.
Polikarpova SB; Lubimova NV; Ogereliev AS; Britvin TA; Davidov MI
Bull Exp Biol Med; 2009 Nov; 148(5):803-6. PubMed ID: 20396797
[TBL] [Abstract][Full Text] [Related]
2. Serotonin, catecholamines, histamine, and their metabolites in urine, platelets, and tumor tissue of patients with carcinoid tumors.
Kema IP; de Vries EG; Slooff MJ; Biesma B; Muskiet FA
Clin Chem; 1994 Jan; 40(1):86-95. PubMed ID: 7507008
[TBL] [Abstract][Full Text] [Related]
3. Influence of carcinoid syndrome on the clinical characteristics and outcomes of patients with gastroenteropancreatic neuroendocrine tumors undergoing operative resection.
Kimbrough CW; Beal EW; Dillhoff ME; Schmidt CR; Pawlik TM; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha FG; Crown A; Abbott DE; Fisher AV; Fields RC; Krasnick BA; Idrees K; Marincola-Smith P; Cho CS; Beems M; Maithel SK; Cloyd JM
Surgery; 2019 Mar; 165(3):657-663. PubMed ID: 30377003
[TBL] [Abstract][Full Text] [Related]
4. Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study.
Halperin DM; Shen C; Dasari A; Xu Y; Chu Y; Zhou S; Shih YT; Yao JC
Lancet Oncol; 2017 Apr; 18(4):525-534. PubMed ID: 28238592
[TBL] [Abstract][Full Text] [Related]
5. [Carcinoid syndrome in neuroendocrine tumors--not easy to recognize].
Milos B
Acta Chir Iugosl; 2013; 60(3):13-6. PubMed ID: 24669575
[TBL] [Abstract][Full Text] [Related]
6. Infection with multidrug-resistant Campylobacter coli mimicking recurrence of carcinoid syndrome: a case report of a neuroendocrine tumor patient with repeated diarrhea.
Lagler H; Kiesewetter B; Raderer M
BMC Infect Dis; 2016 Aug; 16():409. PubMed ID: 27519265
[TBL] [Abstract][Full Text] [Related]
7. Incidence and prognostic value of serotonin secretion in pancreatic neuroendocrine tumours.
Zandee WT; van Adrichem RC; Kamp K; Feelders RA; van Velthuysen MF; de Herder WW
Clin Endocrinol (Oxf); 2017 Aug; 87(2):165-170. PubMed ID: 28464233
[TBL] [Abstract][Full Text] [Related]
8. [Pathological implications in the neuroendocrine gastrointestinal system].
Piette C; Polus M; Louis E
Rev Med Liege; 2002 Aug; 57(8):509-18. PubMed ID: 12405024
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors associated with carcinoid syndrome in patients with gastrointestinal neuroendocrine tumors.
Cai B; Broder MS; Chang E; Yan T; Metz DC
World J Gastroenterol; 2017 Oct; 23(40):7283-7291. PubMed ID: 29142475
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of the pathophysiology of carcinoid crisis.
Condron ME; Jameson NE; Limbach KE; Bingham AE; Sera VA; Anderson RB; Schenning KJ; Yockelson S; Harukuni I; Kahl EA; Dewey E; Pommier SJ; Pommier RF
Surgery; 2019 Jan; 165(1):158-165. PubMed ID: 30415870
[TBL] [Abstract][Full Text] [Related]
11. Increased dopamine production in patients with carcinoid tumors.
Feldman JM
Metabolism; 1985 Mar; 34(3):255-60. PubMed ID: 3974452
[TBL] [Abstract][Full Text] [Related]
12. Partial hepatic resections for metastatic neuroendocrine tumors: perioperative outcomes.
Kinney MAO; Nagorney DM; Clark DF; O'Brien TD; Turner JD; Marienau ME; Schroeder DR; Martin DP
J Clin Anesth; 2018 Dec; 51():93-96. PubMed ID: 30098573
[TBL] [Abstract][Full Text] [Related]
13. Carcinoid syndrome and serotonin: therapeutic effects of ketanserin.
Robertson JI
Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():53-8. PubMed ID: 2285651
[TBL] [Abstract][Full Text] [Related]
14. Prognosis and survival in patients with gastrointestinal tract carcinoid tumors.
Shebani KO; Souba WW; Finkelstein DM; Stark PC; Elgadi KM; Tanabe KK; Ott MJ
Ann Surg; 1999 Jun; 229(6):815-21; discussion 822-3. PubMed ID: 10363895
[TBL] [Abstract][Full Text] [Related]
15. Real-world treatment patterns, resource use and costs of treating uncontrolled carcinoid syndrome and carcinoid heart disease: a retrospective Swedish study.
Lesén E; Björstad Å; Björholt I; Marlow T; Bollano E; Feuilly M; Marteau F; Welin S; Elf AK; Johanson V
Scand J Gastroenterol; 2018 Dec; 53(12):1509-1518. PubMed ID: 30449217
[TBL] [Abstract][Full Text] [Related]
16. Carcinoid syndrome: update on the pathophysiology and treatment.
Rubin de Celis Ferrari AC; Glasberg J; Riechelmann RP
Clinics (Sao Paulo); 2018 Aug; 73(suppl 1):e490s. PubMed ID: 30133565
[TBL] [Abstract][Full Text] [Related]
17. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract.
Rorstad O
J Surg Oncol; 2005 Mar; 89(3):151-60. PubMed ID: 15719376
[TBL] [Abstract][Full Text] [Related]
18. Excretion of histamine and metabolites of 5-hydroxytryptamine in a case of metastasized carcinoid tumour.
MUSTALA OO; AIRAKSINEN MM
Acta Med Scand; 1962 Apr; 171():483-9. PubMed ID: 14477604
[No Abstract] [Full Text] [Related]
19. Carcinoid syndrome from gastrointestinal carcinoids without liver metastasis.
Feldman JM; Jones RS
Ann Surg; 1982 Jul; 196(1):33-7. PubMed ID: 7092350
[TBL] [Abstract][Full Text] [Related]
20. [Right ventricular failure as the presenting manifestation of a carcinoid syndrome].
Poyet R; Kerebel S; Pons F; Aletti M; Jego C; Cellarier GR; Graffin B; Carli P; Carlioz R
Rev Med Interne; 2009 Jan; 30(1):81-4. PubMed ID: 18468735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]